Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress

Overview

Journal Front Pharmacol

Date 2022 Jan 24

PMID 35069189

Authors

Menglong Wang

Jishou Zhang

Mengmeng Zhao

Jianfang Liu

Jing Ye

Yao Xu

Zhen Wang

Di Ye

Dan Li

Jun Wan

Affiliations

Soon will be listed here.

Abstract

Resolvin D1 (RvD1) is a lipid mediator that promotes resolution of inflammation. However, the function of RvD1 in doxorubicin- (Dox-) induced cardiotoxicity remains to be clarified. This study aimed to investigate whether RvD1 could attenuate Dox-induced cardiac injury. The mice were divided into three groups: control, Dox (20 mg/kg, once, intraperitoneally), and Dox + RvD1. RvD1 (2.5 μg/kg, intraperitoneally) was injected daily for 5 days. Echocardiography was performed to evaluate the cardiac function, and the heart tissue and serum samples were collected for further analyses. The results showed that RvD1 attenuated the decreased ratio of heart weight/body weight and heart weight/tibia length, the increased level of creatine kinase and activity of lactate dehydrogenase after Dox treatment. RvD1 improved the ejection fraction and fractional shortening of left ventricular and attenuated the severity of apoptosis induced by Dox. As for the underlying pathways, the results showed that RvD1 reduced the expression of IL-1 and IL-6, and attenuated the phosphorylation of P65 in cardiac tissue. RvD1 attenuated the oxidative stress induced by Dox, as demonstrated by the attenuated levels of superoxide dismutase, glutathione, and malondialdehyde, decreased expression of Nox-2 and Nox-4 and increased expression of Nrf-2 and HO-1. In addition, RvD1 also inhibited the endoplasmic reticulum stress induced by Dox. These results indicate the potential therapeutic benefits of RvD1 in Dox-induced cardiotoxicity in mice, and the mechanism may be related to the attenuated inflammation, oxidative stress and endoplasmic reticulum stress.

Citing Articles

Cardioprotective Effects of Dapagliflozin and Trimetazidine on Doxorubicin-Induced Cardiotoxicity in Streptozotocin-Induced Type 1 Diabetic Rats via Endoplasmic Reticulum Stress.

Ogutveren M, Satiroglu O, Ozden Z, Akyildiz K, Yilmaz A, Mercantepe F J Clin Med. 2025; 14(4).

PMID: 40004844 PMC: 11856595. DOI: 10.3390/jcm14041315.

Resolvin D2/GPR 18 axis ameliorates pressure overload-induced heart failure by inhibiting pro-inflammatory macrophage polarization.

Zheng Z, Zhao M, Xu Y, Zhang J, Peng S, Liu J J Lipid Res. 2024; 65(12):100679.

PMID: 39490925 PMC: 11652778. DOI: 10.1016/j.jlr.2024.100679.

Potential role of endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity-an update.

Sun M, Zhang X, Tan B, Zhang Q, Zhao X, Dong D Front Pharmacol. 2024; 15:1415108.

PMID: 39188945 PMC: 11345228. DOI: 10.3389/fphar.2024.1415108.

Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account.

Vitale R, Marzocco S, Popolo A Int J Mol Sci. 2024; 25(13).

PMID: 39000584 PMC: 11242665. DOI: 10.3390/ijms25137477.

Role of diosmin in preventing doxorubicin-induced cardiac oxidative stress, inflammation, and hypertrophy: A mechanistic approach.

Alasmari A, Al-Shehri M, Algarini N, Alasmari N, Alhazmi A, Alswayyed M Saudi Pharm J. 2024; 32(6):102103.

PMID: 38799001 PMC: 11127263. DOI: 10.1016/j.jsps.2024.102103.

References

Wang L, Zhang T, Zhang Y, Bi H, Guan X, Wang H . Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein. Sci Rep. 2016; 6:28399. PMC: 4914971. DOI: 10.1038/srep28399. View

Fu H, Okada K, Liao Y, Tsukamoto O, Isomura T, Asai M . Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation. 2010; 122(4):361-9. DOI: 10.1161/CIRCULATIONAHA.109.917914. View

Wojnowski L, Kulle B, Schirmer M, Schluter G, Schmidt A, Rosenberger A . NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation. 2005; 112(24):3754-62. DOI: 10.1161/CIRCULATIONAHA.105.576850. View

Jadapalli J, Wright G, Kain V, Sherwani M, Sonkar R, Yusuf N . Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium. Am J Physiol Heart Circ Physiol. 2018; 315(5):H1091-H1100. PMC: 6734064. DOI: 10.1152/ajpheart.00290.2018. View

Chua C, Gao J, Ho Y, Xu X, Kuo I, Chua K . Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice. Cardiovasc Res. 2008; 81(1):20-7. PMC: 2639090. DOI: 10.1093/cvr/cvn257. View

Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald J . D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013; 27(6):2220-32. PMC: 3659350. DOI: 10.1096/fj.12-225615. View

Burgos-Moron E, Abad-Jimenez Z, Maranon A, Iannantuoni F, Escribano-Lopez I, Lopez-Domenech S . Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues. J Clin Med. 2019; 8(9). PMC: 6780404. DOI: 10.3390/jcm8091385. View

Olivares-Silva F, De Gregorio N, Espitia-Corredor J, Espinoza C, Vivar R, Silva D . Resolvin-D1 attenuation of angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension. Biochim Biophys Acta Mol Basis Dis. 2021; 1867(12):166241. DOI: 10.1016/j.bbadis.2021.166241. View

Von Hoff D, Layard M, Basa P, Davis Jr H, Von Hoff A, Rozencweig M . Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979; 91(5):710-7. DOI: 10.7326/0003-4819-91-5-710. View

10.

Zhang X, Qu X, Yang Sun Y, Caruana G, Bertram J, Nikolic-Paterson D . Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation. PLoS One. 2013; 8(6):e67471. PMC: 3696081. DOI: 10.1371/journal.pone.0067471. View

11.

Ye J, Wang Y, Xu Y, Wang Z, Liu L, Wang M . Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice. Redox Biol. 2020; 36:101636. PMC: 7371904. DOI: 10.1016/j.redox.2020.101636. View

12.

Ray P, Huang B, Tsuji Y . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24(5):981-90. PMC: 3454471. DOI: 10.1016/j.cellsig.2012.01.008. View

13.

Lefrak E, Pitha J, ROSENHEIM S, Gottlieb J . A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973; 32(2):302-14. DOI: 10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2. View

14.

Ye J, Wang Y, Wang Z, Liu L, Yang Z, Ye D . Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice. Aging (Albany NY). 2020; 12(1):193-203. PMC: 6977681. DOI: 10.18632/aging.102609. View

15.

Serhan C, Petasis N . Resolvins and protectins in inflammation resolution. Chem Rev. 2011; 111(10):5922-43. PMC: 3192290. DOI: 10.1021/cr100396c. View

16.

Zhang J, Wang M, Ding W, Zhao M, Ye J, Xu Y . Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling. Biochem Pharmacol. 2020; 180:114188. DOI: 10.1016/j.bcp.2020.114188. View

17.

Ye J, Huang Y, Que B, Chang C, Liu W, Hu H . Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice. EBioMedicine. 2018; 35:29-39. PMC: 6154773. DOI: 10.1016/j.ebiom.2018.06.009. View

18.

Buzdar A, Marcus C, Smith T, Blumenschein G . Early and delayed clinical cardiotoxicity of doxorubicin. Cancer. 1985; 55(12):2761-5. DOI: 10.1002/1097-0142(19850615)55:12<2761::aid-cncr2820551206>3.0.co;2-p. View

19.

Salas-Hernandez A, Ruz-Cortes F, Bruggendieck F, Espinoza-Perez C, Espitia-Corredor J, Varela N . Resolvin D1 reduces expression and secretion of cytokines and monocyte adhesion triggered by Angiotensin II, in rat cardiac fibroblasts. Biomed Pharmacother. 2021; 141:111947. DOI: 10.1016/j.biopha.2021.111947. View

20.

Pecoraro M, Del Pizzo M, Marzocco S, Sorrentino R, Ciccarelli M, Iaccarino G . Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol. 2016; 293:44-52. DOI: 10.1016/j.taap.2016.01.006. View